Every year in France, 80,000 diabetic patients develop a foot ulcer, a complication that can be avoided in the majority of cases if detected early. However, prevention tools remain inadequate: unreliable visual inspections, discontinuous podiatry follow-up, lack of daily monitoring.
This white paper, published by Solsius, a French MedTech founded in 2023, provides a comprehensive overview of this public health issue.
It sets out the clinical issues surrounding foot ulcers, the limitations of traditional approaches and the science behind plantar thermomonitoring: a clinically validated solution recommended by the International Working Group on the Diabetic Foot (IWGDF).
This white paper then presents the CE-marked Solsius SelfCare medical device, comprising a connected insole and a mobile application, designed to become part of the patient's daily life and detect the first signs of ulceration before any visible lesions.
It is a reference document for healthcare professionals, decision-makers and MedTech players wishing to understand the challenges of the diabetic foot and the innovative solutions available today.
Dr Jimmy Mohamed, doctor and health columnist on RTL, devotes a column to the diabetic foot: risks, warning signs and the importance of prevention.
This brochure for healthcare professionals presents the plantar temperature monitoring solution developed by Solsius for diabetic patients.
This patient brochure presents the foot temperature monitoring solution developed by Solsius for diabetic patients.
